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Immune repertoires provide a unique fingerprint reflecting the immune history of individuals,
with potential applications in precision medicine. However, the question of how personal that
information is and how it can be used to identify people has not been explored. Here, we show
that individuals can be uniquely identified from repertoires of just a few thousands lymphocytes.
We present “Immprint,” a classifier using an information-theoretic measure of repertoire similarity
to distinguish pairs of repertoire samples coming from the same versus different individuals. Using
published data and statistical modeling, we tested its ability to identify individuals with great
accuracy, including identical twins, by computing false positive and false negative rates < 10−6
using 10,000 cells. The method is robust to acute infections and the passage of time. These results
emphasize the private and personal nature of repertoire data.
Personalized medicine is a frequent promise of next-
generation sequencing. These high-throughput and low-
cost sequencing technologies hold the potential of tai-
lored treatment for each individual. However, progress
comes with privacy concerns. Genome sequences cannot
be anonymized: a genetic fingerprint is in itself enough
to fully identify an individual, with the rare exception of
monozygotic twins. The privacy risks brought by these
pseudonymized genomes have been highlighted by multi-
ple studies [1–3], and the approach is now routinely used
by law enforcement. Sequencing experiments that focus
on a limited number of expressed genes should be less
prone to these concerns. However, as we will show, B-
and T-cell receptor (BCR and TCR) genes are an excep-
tion to this rule.
BCR and TCR are randomly generated through so-
matic recombination [4], and the fate of each B- or T-cell
clone depends on the environment and immune history.
The immune repertoire, defined as the set of BCR or
TCR expressed in an individual, has been hailed a faith-
ful, personalized medical record, and repertoire sequenc-
ing (RepSeq) as a poential tool of choice in personalized
medicine [5–9]. In this report we show that each person’s
repertoire is truly unique. We describe how, from small
quantities of blood (blood spot or heel prick), one can
extract enough information to uniquely identify an indi-
vidual, providing an immune fingerprint, which we call
“Immprint”.
Given two samples of peripheral blood respectively
containing M1 and M2 T cells, we want to distinguish
between two hypothetical scenarios: either the two sam-
ples come from the same individual (“autologous” sce-
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nario), or they were obtained from two different individ-
uals (“heterologous” scenario), see Fig. 1a.
TCR are formed by two protein chains α and β. They
each present a region of high somatic variability, labeled
CDR3α and CDR3β, randomly generated during the re-
combination process. These regions are coded by short
sequences (around 50 nucleotides), which are captured
by RepSeq experiments. The two chains are usually not
sequenced together so that the pairing information be-
tween α and β is lost. Most experiments focus on the β
chain, and we will focus on that chain, but the results are
largely independent of this choice. CDR3β sequences are
very diverse, with more than 1040 possible sequences [10].
For comparison, a human TCR repertoire is composed of
108 to 1010 unique clonotypes [11, 12]. As a result, most
of the sequences found in a repertoire are “private”.
To discriminate between the autologous and heterolo-
gous scenarios, one can count the number of nucleotide
receptor sequences, S, shared between the two samples.
Samples coming from the same individual should have
more receptors in common because T-cells are organized
in clones of cells carrying the same TCR. By contrast, S
should be low in pairs of samples from different individ-
uals, in which sharing is due to rare convergent recom-
binations. Appropriately setting a threshold to jointly
minimize the rates of false positives and false negatives
(Fig. 1b), we can use S as a classifier to distinguish au-
tologous from heterologous samples.
The S score can be improved upon by exploiting the
fact that some receptors are much more likely than oth-
ers to be generated during V(D)J-recombination, with
variations in generation probability (Pgen, [13–15]) span-
ning 15 orders of magnitude. Public sequences (with high
Pgen) are likely to be found in multiple individuals [16],
while rare sequences (low Pgen) are unlikely to be shared
by different individuals, and thus provide strong evidence
for the autologous scenario when found in both samples.
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FIG. 1: a) The two samples A and B can either originate from the same individual (autologous) or two different individuals
(heterologous). In both scenarios, sequences can be shared between the two samples, but their quantity and quality vary. b)
Schematic representation of the distribution of the S or I scores in both scenarios. The dashed vertical line represents the
threshold value. c) Expected value of S and I for different pairs of samples, sampled from the same individual (in blue) or
different ones (orange). Red dots represent samples extracted from pairs of twins. The dashed lines represents the theoretical
upper bound (see Methods) for both S and I (γ = 12). d) Distribution of S in both scenarios (orange heterologous, blue
autologous) for different pairs of samples, M = 5000. The distributions in red correspond to a pair of samples extracted
from twins. e) Detection Error Trade-off (DET) graph for both summary statistics and different sample sizes M . I (γ = 12)
outperforms S in all scenarios. f) AUROC (Area Under Receiver Operating Characteristic), as a function of M . The AUROC
is a traditional measure of the quality of a binary classifier (a score closer to one indicates a better classifier). The results are
shown for S and I both in the default case (only the β chain considered) or for the full (α-β) receptor.
To account for this information, we define the score:
I =
∑
shared s
[ln (1/Pgen(s))− γ] , (1)
which accounts for Shannon’s “surprise” ln(1/Pgen)—a
measure of unexpectedness—associated with each shared
sequence s, so that rare shared sequences count more
than public ones. The constant γ depends on the reper-
toire’s clonal structure and is set to 12 in the following
(see Methods for an information-theoretic derivation).
Pgen is computed using models previously trained on data
from multiple individuals [14]. Small differences reported
between the Pgen of distinct individuals justify the use of
a universal model [15].
We tested the classifiers based on the S and I scores
on TCRβ RepSeq datasets from 656 individuals [17]. Se-
quences were downsampled to mimic experiments where
M1 = M2 = M cells were analyzed (including a pro-
cedure to correct for the limited diversity of the sam-
pled repertoire relative to the full repertoire, see Meth-
ods I). Similar results may be obtained when M1 and
M2 are different (see Methods). In Fig. 1c, we plot the
mean value of S (over many draws of M = 5000 recep-
tors) for each individual (autologous scenario, in blue)
and between pairs of different individuals (heterologous
scenario, in orange). The two scenarios are clearly dis-
cernable under both scores This result holds for pairs of
monozygotic twins obtained from a distinct dataset [18]
(pink dots), consistent with previous reports that twins
differ almost as much in their repertoires as unrelated in-
dividuals [18–20]. Heterologous scores (orange dots) vary
little, and may be bounded from above by a theoretical
prediction (dashed line) based on a model of recombina-
tion [21] (see Methods). On the other hand, autologous
scores (blue dots) show several orders of magnitude of
variability across individuals. These variations stem from
the clonal structure of the repertoire, and correlates with
measures of diversity (Fig. S1), which is known to vary
a lot between individuals and correlates with age [22],
serological status, and infectious disease history [23, 24].
To explore the worst case scenario of discriminability,
hereafter we will focus on the individual with the lowest
autologous S found in the dataset.
The sampling process introduces an additional source
of variability within each individual. Two samples of
blood from the same individual do not contain the exact
same receptors, and the values of S and I is expected to
vary between replicates. Example of distributions for S
3between different pairs of replicates in the same (blue)
and in different individual are given in Fig. 1d. The dis-
tribution of S is well-approximated by a Poisson distribu-
tion, while I follows approximately a compound distribu-
tion of a normal and Poisson distributions (see Methods
for details). Armed with these statistical models of varia-
tions, we can predict upper bounds for the false negative
and false positive rates. As seen from the detection error
trade-off (DET) graph Fig. 1e, the Immprint classifier
performs very well for a few thousand receptors with an
advantage for I.
With 10, 000 cells, corresponding to ∼ 10 µL of blood,
Immprint may simultaneously achieve a false positive
rate of < 10−16 and false negative rate of < 10−6, al-
lowing for the near-certain identification of an individ-
ual in pairwise comparisons against the world population
∼ 1010. When a large reference repertoire has been col-
lected (M1 = 1, 000, 000, corresponding from ∼ 1mL of
blood), an individual can be identified with just 100 cells
(Fig. S2).
The AUROC estimator (Area Under the Curve of the
Receiver Operating Characteristic), a typical measure
of a binary classifier performance, can be used to score
the quality of the classifier with a number between 0.5
(chance) and 1 (perfect classification). The I score out-
performs the S score (Fig. 1f), particularly above moder-
ate sample sizes (M ≈ 5000). Both scores can be readily
generalized to the case of paired receptors TCRαβ, when
the pairing of the two chains is available (through single-
cell sequencing [25–27] or computational pairing [28]),
using Pgen (α, β) = Pgen (α)×Pgen (β) [29] for the gener-
ation probability of the full TCR. Because coincidental
sharing of both chains is substantially rarer than with the
β chain alone, using the paired chain information greatly
improves the classifier.
The previous results used samples obtained at the same
time. However, immune repertoires are not static: inter-
action with pathogens and natural aging modify their
composition. The evolution of clonal frequencies will
decrease Immprint’s reliability with time, especially if
the individual has experienced immune challenges in the
meantime.
To study the effect of short-term infections, we ana-
lyzed an experiment where 6 individuals were vaccinated
with the yellow fever vaccine, which is regarded as a good
model of acute infection, and their immune system was
monitored regularly through blood draws [18]. We ob-
serve an only moderate drop in S caused by vaccination
(Fig. 2a). This is consistent with the fact that infections
lead to the strong expansion of only a limited number of
clones, while the rest of the immune system stays stable
[30–33]. While other types of infections, auto-immune
diseases, and cancers may affect Immprint in more sub-
stantial ways, our result suggests that it is relatively ro-
bust to changes in condition.
We then asked how stable Immprint is over long times.
Addressing this issue is hampered by the lack of longi-
tudinal datasets over long periods, so we turn to math-
ematical models [12, 34–37] to describe the dynamics of
the repertoire. Following the model of fluctuating growth
rate described in Ref. [36], we define two typical evolu-
tionary timescales for the immune system: τ , the typical
turnover rate of T-cell clones, and θ, which represents
the typical time for a clonotype to grow or shrink by
a factor two as its growth rate fluctuates. The model
predicts a power-law distribution for the clone-size dis-
tribution, with exponent −1 − τ/2θ. This exponent has
been experimentally measured to be ≈ −2, which leaves
us with a single parameter τ , and θ = τ/2. An example
of simulated evolution of Immprint with time is shown
in Fig. 2b. The highlighted histogram represents a data
point at two years obtained from [38]. While a fit is pos-
sible for this specific individual, the τ parameter is not
universal, and we expect it to vary between individuals,
especially as a function of age. In Fig. 2c we explore a
range of reasonable values for the clone turn-over rate
τ (from 6 months to 10 years), and their effect on the
stability of Immprint. We observe that for most individ-
uals, bar exceptional events, Immprint should conserve
its accuracy for years or even decades.
In summary, we demonstrated that the T-cells present
in small blood samples provide a somatic and long-
lived barcode of human individuality, which is robust
to immune challenges and stable over time. Unlike
genome sequencing, repertoire sequencing can discrim-
inate monozygotic twins with the same accuracy as un-
related individuals. However, a person’s unique immune
fingerprint can be completely wiped out by a hematopoi-
etic stem cell transplant [39]. Immprint is implemented in
a python package and webapp (see Methods) allowing the
user to determine the autologous or heterologous origin
of a pair of repertoires. Beyond identifying individuals,
the tool could be used to check for contamination or la-
belling errors between samples containing TCR informa-
tion. The repertoire information used by Immprint can
be garnered not only from RepSeq experiments, but also
from RNA-Seq experiments, which contain thousands of
immune receptor transcripts [40, 41]. Relatively small
samples of immune repertoires are enough to uniquely
identify an individual even among twins, with potential
forensics applications. At the same time, unlike genetic
data from genomic or mRNA sequencing, Immprint pro-
vides no information about kin relationships, very much
like classical fingerprints, and avoids privacy concerns
about disclosing genetic information shared with non
consenting relatives.
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FIG. 2: a) Evolution of S during vaccination, between a sample taken at day 0 (vaccination date) and at a later timepoint.
Each color represents a different individual. Each pair timepoint/individual has two biological replicates. The dashed line
represents the threshold value. b) Evolution of S between a sample taken at year 0 and a later timepoint. Blue histograms
show theoretical estimates, and the red histogram corresponds to a real dataset. c) Evolution of the (normalized) mean of S
as a function of time for different values of the turnover rate τ . The dashed line represents the threshold value divided by the
smallest value of St=0 in the data.
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6I. METHODS
Datasets & Pre-processing
We use four independant RepSeq datasets in this study: (i) genomic DNA from Peripheral blood mononuclear cells
(PBMCs) from 656 healthy donors [17]; (ii) cDNA of PBMCs sampled from three pairs of twins, before and after a
yellow-fever vaccination [18]; (iii), (iv) two longitudinal studies of healthy adults [22, 38] .
CDR3 nucleotide sequences were extracted with MIGEC [42] (for the second dataset) coupled with MiXCR [43].
We also extract the frequency of reads from the three datasets. The non-productive sequences were discarded (out-
of-frame, non-functional V gene, or presence of a stop codon). The generation probability (Pgen) was computed using
OLGA [44], with the default TCRβ model. The frequency of each clone was estimated through the number of reads,
which we use as an imperfect proxy for the number of cells.
The preprocessing code is distributed on the Git repository associated with the paper. We also developed a
command-line tool (https://github.com/statbiophys/Immprint) that discriminates between sample origins, and
a companion webapp (https://immprint.herokuapp.com).
Discrimination scores
To discriminate between the autologous and heterologous scenarios, we introduce a log-likelihood ratio test between
the two possibilities:
I =
∑
s
ln
P (y1(s), y2(s)|autologous)
P (y1(s), y2(s)|heterologous) , (2)
where y1(s) = 1 if the sequence s is found in sample 1, and 0 otherwise; likewise y2(s) = 1 if s is in sample 2. The
sum runs over all potential sequences s, including unseen ones. To be present in a sample, a sequence s first has to be
present in the repertoire. This occurs with probability 1− (1− p(s))Nc , where Nc is the total number of clonotypes
in the repertoire, and p(s) is the probability of occurence of sequence s (resulting from generation and selection, see
below). Second, it must be picked in a sample of size M , with probability 1− (1− f)M ≈ Mf (assuming Mf  1)
depending on its frequency f , which is distributed according to the clone size distribution ρ(f). We checked that f(s)
and Pgen(s) were not correlated (Fig. S3). Then one can write
P (y1(s) = 1, y2(s) = 1 | autologous) ≈
(
1− e−Ncp(s)
)
M1M2
∫
df ρ(f) f2, (3)
P (y1(s) = 1, y2(s) = 0 | autologous) ≈
(
1− e−Ncp(s)
)M1
Nc
and 1↔ 2, (4)
P (y1(s) = 0, y2(s) = 0 | autologous) ≈ 1−
(
1− e−Ncp(s)
)M1 +M2
Nc
, (5)
where we’ve used
∫
df ρ(f) f = 1/Nc. For the heterologous case the probability factorizes as:
P (y1(s), y2(s) | heterologous) = P1(y1(s))P2(y2(s)), (6)
with
Pa(ya(s) = 1) ≈
(
1− e−Ncp(s)
)Ma
Nc
, a = 1, 2. (7)
Since only the term y1(s) = y2(s) = 1 (shared sequences) is different between the autologous and heterologous cases,
we obtain:
I =
∑
shared s
[
ln(N2c 〈f2〉)− ln
(
1− e−Ncp(s)
)]
. (8)
Further assuming Ncp(s) 1, and p(s) = Pgen(s)q−1 (where q accounts for selection [21] and Pgen(s) is the probability
of sequence generation [14]), the score simplifies to Eq. 1, with γ = − ln(qNc〈f2〉) = ln(q−1〈f〉/〈f2〉). The factor
γ depends on unknown parameters of the model, but can be estimated assuming a power-law for the clone size
distribution [45], ρ(f) ∝ f−2 extending from f = 10−11 to f = 0.01, and q = 0.01 [21], yielding γ ≈ 12.24.
Alternatively we optimized γ to minimize the AUROC, yielding γ ≈ 15 (SI Fig. S4). Since performance degrades
quickly for larger values, we conservatively set γ = 12.
7Estimating mean scores from RepSeq datasets
To estimate the autologous S and I of two samples of size M1 and M2 in the absence of true replicates, we computed
their expected values from a single dataset containing N reads, from which two random subsamples of sizes M1 and
M2 were taken. The mean value of S is equal to 〈S〉 =
∑
s(1− (1− f(s))M1)(1− (1− f(s))M2), where f(s) is the true
(and unknown) frequency of sequence s. A naive estimate of 〈mS〉 may be obtained by repeatly resampling subsets
of sizes M1 and M2 from the observed repertoire, calculate S for each draw, and average. One get the same result by
replacing f(s) by fˆs = n(s)/N in the previous formula, where n(s) is the number of s reads in the full dataset, and
N =
∑
s n(s). However, this naive estimate leads to a systematic overestimate of the sharing (visible when compared
with biological replicates, see Fig. S5), simply because this procedure overestimates the probability of resampling rare
sequences, in particular singletons whose true frequency may be much lower that 1/N . A similar bias occurs when
computing I. To correct for this bias, we look for a function h(n) that satisfies for all f :
〈h(n)〉 ≡
∑
n
(
N
n
)
fn(1− f)N−nh(n) = (1− (1− f)M1) (1− (1− f)M2), (9)
so that 〈S〉 and 〈I〉 can be well approximated by:
〈S〉 ≈
∑
s
h(n(s)), (10)
〈I〉 ≈ −
∑
s
h(n(s)) [ln(1/Pgen(s))− γ] . (11)
Expanding the right-hand side of Eq. 9 into 4 terms, we find that h(n) = 1−gM1(n)−gM1(n)+gM1+M2(n) satisfies
Eq. 9 provided that: ∑
n
(
N
n
)
fn(1− f)N−ngM (n) = (1− f)M . (12)
Under the change of variable x = f/(1− f), the expression becomes:∑
n
(
N
n
)
xngM (n) = (1 + x)
N−M =
∑
n
(
N −M
n
)
xn. (13)
Identifying the polynomial coefficients in xn on both sides yields:
gM (n) =
(
N −M
n
)/(
N
n
)
. (14)
These corrected estimates agree with the direct estimates using biological replicates (Fig. S5).
Similarly, 〈S〉 and 〈I〉 in heterologous samples can be estimated using:
〈S〉 ≈
∑
s
[1− gM1(n(s))][1− gM2(n′(s))], (15)
〈I〉 ≈
∑
s
[1− gM1(n(s))][1− gM2(n′(s))] [ln(1/Pgen(s))− γ] . (16)
where n(s) and n′(s) are the empirical counts of sequence s in the two samples.
Theoretical upper bound on heterologous scores
When the two samples were extracted from two different people (heterologous scenario), we can use the universality
of the recombination process to give upper bounds on the values of S and I. These bounds are represented by the
dashed lines in Fig1c). If two samples of respectively M1 and M2 unique sequences are extracted from two different
individuals, the number of shared sequences between them is given by [21]:
〈S〉heterologous ≤
∑
s
(
1− (1− p(s))M1
)(
1− (1− p(s))M2
)
/M1M2
∑
s
p(s)2 = M1M2〈p(s)〉. (17)
8p(s) is the probability of finding a sequence s in the blood. Following [21], we make the approximation p(s) =
Pgen(s)q
−1, where the q = 0.01 factor is the probability that a generated sequences passes selection. Then 〈p(s)〉 can
be estimated from the mean over generated sequences. Similarly, we can estimate I as
〈I〉heterologous /M1M2
∑
s
p(s)2 [ln (1/Pgen(s))− γ] = −M1M2〈p(s)[γ + ln(qp(s))]〉, (18)
which is also estimated from the mean over generated sequences.
Error rate estimates
To make the quantitative predictions shown in Fig. 1, we need to constrain the tail behavior of the distributions of
S and I, for the two scenarios.
The S statistic can be rewritten as a sum of Bernouilli variables over all possible sequences, each with a parameter
corresponding to its probability of being present in both samples, either in the autologous or the heterologous case.
Therefore S is a Poisson binomial distribution, a sum of independent Bernouilli variables with potentially different
parameters. The variance and tails of that distribution are bounded by those of the Poisson distribution with the
same mean, denoted by ma for the autologous case, and mh for the heterologous case (Fig. S6).
Thanks to that inequality, the rates of false negatives and false positives for a given threshold r are bounded by:
P (S < r|autologous) ≤ Q(r + 1,ma), P (S > r|heterologous) ≤ 1−Q(r + 1,mh), (19)
where Q is the regularized gamma function, which appears in the cumulative distribution function of the Poisson
distribution. The mean autologous score ma is estimated from experimental data: we use the smallest value of 〈S〉 in
the Emerson dataset and Eq. 10. To compute mh, we use the semi-theoretical prediction made using the universality
of the recombination process, Eq. 17.
Similarly, I can be viewed as a sum of S independent random variables, all following the distribution of ln(1/Pgen)−
γ. However, this distribution differs in the two scenarios. Sequences shared between more than one donor have an
higher probability of being generated, their ln(Pgen) distribution has higher mean and smaller variance (Fig. S7).
The sum is composed of a relatively large number of variables in most realistic scenarios. Hence, we rely on the
central limit theorem to approximate it by a normal distribution, of mean and variance proportional to S. Explicitly:
P (I < r|autologous) = 1
2
∞∑
S=0
(ma)
S
e−ma
S!
(
1 + erf
(
r − S〈ln(1/Pgen)− γ〉√
2SVar[ln(1/Pgen)− γ]
))
, (20)
P (I > r|heterologous) = 1
2
∞∑
S=0
(mh)
S
e−mh
S!
(
1− erf
(
r − S〈ln(1/Pgen)− γ〉shared√
2SVar[ln(1/Pgen)− γ]shared
))
. (21)
The AUROC are computed based on these estimates, by numerically integrating the true positive rate P (S, I <
r|heterologous) with respect to the false negative rate P (S, I < r|autologous) as the threshold r is varied.
Modeling the evolution of autologous scores
We use the model of Ref. [36] to describe the dynamics of individual T- or B-cell clone frequencies f under a
fluctuating growth rate reflecting the changing state of the environment and the random nature of immune stimuli:
df
dt
=
[
−1
τ
+
1
2θ
+
1√
θ
η(t)
]
f(t), (22)
where η(t) is a Gaussian white noise with 〈η(t)〉 = 0 and 〈η(t)η(t′)〉 = δ(t− t′).
With the change of variable x = ln(f), these dynamics simplify to a simple Brownian motion in log-frequency:
∂tx = −τ−1 + θ−1/2η(t). In that equation, τ appears as the decay rate of the frequency, while θ is the timescale
of the noise, interpreted as the typical time it takes for the frequency to rise or fall by a logarithmic unit owing to
fluctuations. Considering a large population of clone, each with their independent frequency evolving according to
Eq. 22, and a source term at small f corresponding to thymic exports, one can show that the steady-state probability
9density function of f follows a power-law [36], ρ(f) ∝ f−α, with exponent α = 1 + 2θ/τ . α was empirically found to
be ≈ 2 in a wide variety of immune repertoires [10, 45–47], implying 2θ ≈ τ . The turn-over time τ is unknown, and
was varied from 1/2 year to 10 years in the simulations.
We simulated the evolution of human TRB repertoires by starting with the empirical values of the frequencies of
each observed clones, f(s, 0) = fˆ(s, 0) = n(s, 0)/N from the analysed datasets. A sample of size M was randomly
selected with respect to these frequencies, and the frequencies of the clones captured in that sample were then evolved
with a time-step of 2 days using Euler-Maruyama’s method, which is exact in the case of Brownian motion. Clones
with frequencies falling below 10−11 (corresponding to a single cell in the organism) were removed. At each time t > 0,
we measured the mean value of S with the formula ∑s(1 − (1 − f(s, t))M ) where the sum runs over the sequences
captured in the initial sample.
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FIG. S1: Comparison between the mean of S (autologous case), and three common diversity measures: the number of unique
sequences found in the dataset (top left), the Shannon index, −∑ fˆs ln fˆs (top right), the Simpson index (bottom left), and
the total number of reads in each datasets (bottom right). All the diversity measures show a strong correlation with S, but
the correlation with the sequencing depth is low.
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FIG. S2: Detection Error Trade-off (DET) graph for both summary statistics, between a large sample (full dataset, M1 = 10
6)
and a smaller one, of size M2 = M .
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FIG. S3: Left: Mean value of Pgen as a function of the rank of the clonotype, for generic sequences (blue) and sequences
shared between more than two donors (orange). The mean stays flat indicating that the probability of being generated does
not generally depend on the clonotype size. There is an exception (black rectangle), shown as a close-up on the right panel.
The top twenty clones, when shared between donors, have a smaller probability of being generated than expected by chance.
This difference is likely to be driven by convergent selection against common pathogens, since CMV positive donors show a
more prononced effect than CMV negative ones.
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FIG. S4: Left panel: AUROC (Area Under Receiver Operating Characteristic) of I, as a function of γ (M = M1 = M2 = 5000).
We observe an optimum near γ = 15. Right panel: AUROC as a function of M , for S, I(γ = 0), and I(γ = 15).
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FIG. S5: Naive and corrected estimates of the autologous S from single datasets, versus its values computed using true biological
replicates from Ref. [18].
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FIG. S6: Comparison between the distribution of S obtained by computationally and repeatedly downsampling a single
repertoire from Ref. [17] with M = 5, 000 (histogram), and a Poisson distribution of the same mean (full line).
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FIG. S7: Distribution of ln(Pgen) for generic sequences, and for sequences shared between heterologous samples.
